ReviR Therapeutics

Revi R Therapeutics

Biotechnology, 600 Gtwy BLVD, South San Francisco, California, 94080, United States, 11-50 Employees

revirtx.com

  • LinkedIn

Who is REVIR THERAPEUTICS

ReviR Therapeutics is a research and development company whose mission is to harness advanced technologies, machine learning/AI, and the inherent biology embedded within RNA to develop no...

Read More

map
  • 600 Gtwy BLVD, South San Francisco, California, 94080, United States Headquarters: 600 Gtwy BLVD, South San Francisco, California, 94080, United States
  • 2021 Date Founded: 2021
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies
  • Peng Yue CEO:   Peng Yue

industries-icon Industry: Biotechnology

checked-icon Does something look wrong? Fix it. | View contact records from REVIR THERAPEUTICS

ReviR Therapeutics Org Chart and Mapping

Employees

Kendra Lew

Research Associate II

Yang Li

Co-Founder & Chairman

Praveen Kumar

Director of Translational Biology

Jawad Abid

Research Associate II

Xing Tang

Director of Computational Biology

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding ReviR Therapeutics

Answer: ReviR Therapeutics's headquarters are located at 600 Gtwy BLVD, South San Francisco, California, 94080, United States

Answer: ReviR Therapeutics's official website is https://revirtx.com

Answer: ReviR Therapeutics's revenue is $1 Million to $5 Million

Answer: ReviR Therapeutics has 11-50 employees

Answer: ReviR Therapeutics is in Biotechnology

Answer: ReviR Therapeutics contact info: Phone number: Website: https://revirtx.com

Answer: ReviR Therapeutics is a research and development company whose mission is to harness advanced technologies, machine learning/AI, and the inherent biology embedded within RNA to develop novel medicines to treat human disease. Our AI-based platform allows us to expand beyond the protein-based target space to reach a large number of known disease targets previously considered undruggable Strategies * Invent and build technologies to unlock first-in-class medicines for the treatment of cancer, rare genetic disorders, and infectious diseases * Decipher disease relevant structural and functional RNA motifs by integrating human genetic data, functional genomics, and AI * Integrate Machine Learning tools and advanced the mechanistic understanding of the RNA life cycle at scale in order to deliver transformative therapies for millions of patients

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access